Why do drugs for acute heart failure fail?
Author:
Affiliation:
1. Department of Cardiology; University Medical Center Groningen, University of Groningen; Hanzeplein 1 9713 GZ Groningen The Netherlands
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hfs122/fullpdf
Reference13 articles.
1. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC;McMurray;Eur J Heart Fail,2012
2. Heart Failure Association of ESC (HFA). EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot);Maggioni;Eur J Heart Fail,2010
3. Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes;Gheorghiade;Eur J Heart Fail,2012
4. Soluble guanylate cyclase: a potential therapeutic target for heart failure;Gheorghiade;Heart Fail Rev,2012
5. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure;Lapp;Circulation,2009
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries;Circulation;2023-01-10
2. Empagliflozin in patients hospitalized for acute decompensated heart failure: an expert resolution on the discussion of the EMPULSE trial;Russian Journal of Cardiology;2022-03-17
3. Discovery and Development of the Soluble Guanylate Cyclase Stimulator Vericiguat for the Treatment of Chronic Heart Failure;Contemporary Accounts in Drug Discovery and Development;2022-03-07
4. Serum Free Fatty Acids Independently Predict Adverse Outcomes in Acute Heart Failure Patients;Frontiers in Cardiovascular Medicine;2021-12-22
5. Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial;European Journal of Heart Failure;2021-03-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3